S&CO Inc. Has $16.39 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

S&CO Inc. trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,037 shares of the healthcare conglomerate's stock after selling 1,195 shares during the period. UnitedHealth Group makes up approximately 1.1% of S&CO Inc.'s holdings, making the stock its 26th biggest holding. S&CO Inc.'s holdings in UnitedHealth Group were worth $16,392,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD boosted its position in shares of UnitedHealth Group by 0.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate's stock worth $12,893,331,000 after buying an additional 94,641 shares during the period. Bank of New York Mellon Corp boosted its position in UnitedHealth Group by 0.4% during the second quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate's stock valued at $4,094,247,000 after purchasing an additional 35,533 shares during the last quarter. International Assets Investment Management LLC raised its stake in shares of UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate's stock valued at $1,942,956,000 after buying an additional 880,183 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its position in UnitedHealth Group by 0.6% during the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate's stock worth $1,920,039,000 after acquiring an additional 21,149 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Down 0.2 %

Shares of NYSE:UNH traded down $0.92 during mid-day trading on Friday, reaching $592.23. 3,423,919 shares of the company's stock were exchanged, compared to its average volume of 3,119,612. The firm has a market capitalization of $545.02 billion, a price-to-earnings ratio of 38.58, a PEG ratio of 1.74 and a beta of 0.58. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The business's fifty day moving average price is $582.84 and its 200-day moving average price is $549.98. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion during the quarter, compared to analysts' expectations of $99.14 billion. During the same quarter in the prior year, the firm posted $6.56 earnings per share. The business's quarterly revenue was up 9.2% on a year-over-year basis. On average, research analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date is Monday, December 9th. UnitedHealth Group's dividend payout ratio is presently 54.72%.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of research analyst reports. Truist Financial reaffirmed a "buy" rating and issued a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Barclays decreased their price target on shares of UnitedHealth Group from $604.00 to $603.00 and set an "overweight" rating on the stock in a research note on Tuesday, October 22nd. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Tuesday, November 12th. Cantor Fitzgerald increased their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 16th. Finally, Morgan Stanley cut their price target on UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating for the company in a research note on Wednesday, October 16th. Three investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.